Immobilized SLAMF7/CRACC/CD319 hFc Chimera, Human, His Tag at 0.5 μg/ml (100 μl/well) on the plate. Dose response curve for Biotinylated Anti-SLAMF7 Antibody, hFc Tag with the EC50 of 10.7 ng/ml determined by ELISA.
The purity of SLAMF7/CRACC/CD319 hFc Chimera, Human is greater than 95% as determined by SEC-HPLC.
SLAMF7/CRACC/CD319 hFc Chimera, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.
SLAMF7/CRACC/CD319 hFc Chimera, Human
CD2-like receptor activating cytotoxic cells (CRACC), also known as CS1, novel Ly9, SLAMF7, and CD319, is a 65-75 kDa type I transmembrane glycoprotein in the SLAM subgroup of the CD2 family.Self-ligand receptor of the signaling lymphocytic activation molecule (SLAM) family. SLAM receptors triggered by homo- or heterotypic cell-cell interactions are modulating the activation and differentiation of a wide variety of immune cells and thus are involved in the regulation and interconnection of both innate and adaptive immune response.
| Z04282 | |
|
|
|
| ￥2100 | |
|
|
|
|
|
|
| 联系我们 | |
